Boston Scientific Subsidiaries Barred From Selling Multiple Drug-Eluting Stent Lines In Germany
This article was originally published in The Gray Sheet
Executive Summary
A German court had previously blocked Boston Scientific’s German subsidiary from selling drug-eluting stents affected by OrbusNeich’s patent suit; the new injunction closes a loophole, preventing any Boston Scientific subsidiary from selling the devices in Germany.
You may also be interested in...
News In Brief
Maquet acquires LAAx. OrbusNeich says it called the cops on Boston Scientific. More news
News In Brief
Two deputy commissioners depart FDA. NICE takes over U.K. program to encourage adoption of new medical technologies. More news.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.